[1] Chai J L, Siegmund S E, Hirsch M S, et al. Low-grade oncocytic tumor: a review of radiologic and clinical features[J].Abdom Radiol (NY),2024,49(6):1940-1948.
[2] Humphrey P A, Moch H, Cubilla A L, et al. The 2016 WHO classification of tumours of the urinary system and male genital organs-part b: prostate and bladder tumours[J].Eur Urol,2016,70(1):106-119.
[3] Moch H, Amin M B, Berney D M, et al. The 2022 World Health Organization Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular Tumours[J].Eur Urol,2022,82(5):458-468.
[4] Hes O, Trpkov K. Do we need an updated classification of oncocytic renal tumors? Emergence of low-grade oncocytic tumor (LOT) and eosinophilic vacuolated tumor (EVT) as novel renal entities[J].Mod Pathol,2022,35(9):1140-1150.
[5] 侯红梅, 乔亚男, 董 敏. 经阴道彩色多普勒超声联合肿瘤标志物CA125诊断卵巢上皮性肿瘤的临床价值[J].医学影像学杂志,2019,29(2):286-289.
[6] Mansoor M, Siadat F, Trpkov K. Low-grade oncocytic tumor (LOT) -a new renal entity ready for a prime time: An updated review[J].Histol Histopathol,2022,37(5):405-413.
[7] 刘 鑫, 王 璇, 叶胜兵, 等. 低级别嗜酸细胞性肾肿瘤14例临床病理分析[J].临床与实验病理学杂志,2024,40(4):358-362.
[8] Sasaguri K, Takahashi N, Gomez-Cardona D, et al. Small (< 4 cm) renal mass: differentiation of oncocytoma from renal cell carcinoma on biphasic contrast-enhanced CT[J].AJR Am J Roentgenol,2015,205(5):999-1007.
[9] Allen B C, Tirman P, Jennings C M, et al. Characterizing solid renal neoplasms with MRI in adults[J].Abdom Imaging,2014,39(2):358-387.
[10] Hötker A M, Mazaheri Y, Wibmer A, et al. Differentiation of clear cell renal cell carcinoma from other renal cortical tumors by use of a quantitative multiparametric MRI Approach[J].AJR Am J Roentgenol,2017,208(3):W85-91.
[11] Tjota M Y, Wanjari P, Segal J, et al. TSC/MTOR-mutated eosinophilic renal tumors are a distinct entity that is CK7+/CK20^-/vimentin^-: a validation study[J].Hum Pathol,2021,115:84-95.
[12] 陈 怡, 李 明, 张 涛. 琥珀酸脱氢酶缺陷型肾细胞癌研究进展[J].武警医学,2021,32(12):1095-1098.
[13] Marko J, Craig R, Nguyen A, et al. Chromophobe renal cell carcinoma with radiologic-pathologic correlation[J].Radiographics,2021,41(5):1408-1419.
[14] Honda Y, Nakamura Y, Goto K, et al. Tubulocystic renal cell carcinoma: a review of literature focused on radiological findings for differential diagnosis[J].Abdom Radiol (NY),2018,43(7):1540-1545.
[15] Kapur P, Gao M, Zhong H, et al. Eosinophilic vacuolated tumor of the kidney: A review of evolving concepts in this novel subtype with additional insights from a case with MTOR mutation and concomitant chromosome 1 loss[J].Adv Anat Pathol,2021,28(4):251-257.
[16] Ricci C, Ambrosi F, Franceschini T, et al. Evaluation of an institutional series of low-grade oncocytic tumor (LOT) of the kidney and review of the mutational landscape of LOT[J].Virchows Arch,2023,483(5):687-698.
[17] Schieda N, Davenport M S, Silverman S G, et al. Multicenter evaluation of multiparametric MRI clear cell likelihood scores in solid indeterminate small renal masses[J].Radiology,2022,303(3):590-599.
[18] Akgul M, Obaidy K I, Cheng L, et al. Low-grade oncocytic tumour expands the spectrum of renal oncocytic tumours and deserves separate classification: a review of 23 cases from a single tertiary institute[J].J Clin Pathol,2022,75(11):772-775.
[19] Trpkov K, Williamson S R, Gao Y, et al. Low-grade oncocytic tumour of kidney (CD117-negative, cytokeratin 7-positive): a distinct entity?[J].Histopathology,2019,75(2):174-184.
[20] Nassour A J, Jain A, Hui N, et al. Relative risk of bladder and kidney cancer in lynch syndrome: systematic review and meta-analysis[J].Cancers (Basel),2023,15(2):12.